Landscape of sialylation patterns identify biomarkers for diagnosis and prediction of response to anti-TNF therapy in crohn’s disease
Crohn’s disease (CD), a subtype of inflammatory bowel disease (IBD), causes chronic gastrointestinal tract inflammation. Thirty percent of patients do not respond to anti-tumor necrosis factor (TNF) therapy. Sialylation is involved in the pathogenesis of IBD. We aimed to identify potential biomarker...
Main Authors: | Chenglin Ye, Sizhe Zhu, Yuan Gao, Yabing Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.1065297/full |
Similar Items
-
Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
by: Chenglin Ye, et al.
Published: (2022-04-01) -
An Unusual Presentation of Tuberculosis in a Crohn’s Disease Patient Treated With Anti-TNF
by: Luísa Leite Barros, et al.
Published: (2022-01-01) -
Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn’s Disease
by: Min Seob Kwak, et al.
Published: (2022-03-01) -
Targeting AQP9 enhanced the anti-TNF therapy response in Crohn's disease by inhibiting LPA-hippo pathway
by: Minhao Yu, et al.
Published: (2024-05-01) -
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
by: Elen Farinelli de Campos Silva, et al.
Published: (2018-10-01)